MAY 01, 2015 10:10 PM PDT

What if you could create a blood type that worked for any patient?

WRITTEN BY: Robert Woodard
Donation pathway for ABO blood groups.There are strict rules to blood transfusion. Only blood without A- or B-type antigens, such as type O, can be given to all of those in need. But it's usually in short supply and thousands of patients need it every day.

Those rules may soon change.

As reported in the ACS Journal of the American Chemical Society, a group of scientists have found an efficient way to transform A and B blood into a neutral type that can be given to any patient.

As it stands now, blood transfusions require that the blood type of the donor match that of the recipient. If they don't, there are serious consequences-unless the donor has the blood type O, which can be given to anyone because it doesn't have the A or B antigens that could provoke an immune reaction.

Basically that is because the difference in A, B and O blood types is the presence of slightly different sugar structures on the outside of the red blood cells of each type. Type A and B blood cells each have a single additional sugar attached to their surface.

It makes sense that by removing these sugars, there may be a to convert blood types A and B into type O. And a search for a method to do just that has been going on for some time.

Bacterial enzyme have been identified that can clip the sugars off red blood cells that give blood its "type." But the process isn't efficient enough to give any confident results.

Stephen G Withers and his colleagues wanted to see if they could boost the enzymes' activity. So they did.

By modifying one of those enzymes, they improved its ability to remove type-determining sugars by 170-fold, rendering it antigen-neutral and more likely to be accepted by patients regardless of their blood type.

This discovery could have an impact beyond blood infusion by potentially allowing organ and tissue transplants from donors that would otherwise be mismatched.

The authors acknowledge support from the Canadian Blood Services, the Canadian Institutes of Health Research, Health Canada and the Michael Smith Foundation for Health Research.

Reference:
David H. Kwan, Iren Constantinescu, Rafi Chapanian, Melanie A. Higgins, Miriam P Kötzler, Eric Samain, Alisdair B. Boraston, Jayachandran N. Kizhakkedathu, Stephen G. Withers. Toward Efficient Enzymes for the Generation of Universal Blood through Structure-Guided Directed Evolution. Journal of the American Chemical Society, 2015; 150424072906003 DOI: 10.1021/ja5116088
About the Author
You May Also Like
MAR 11, 2021
Immunology
Bye-Bye Burning: A New UTI Vaccine
MAR 11, 2021
Bye-Bye Burning: A New UTI Vaccine
Researchers have developed a vaccine that “trains” the bladder to fight back against the bacteria that cause ...
MAR 18, 2021
Immunology
"Brainwashed" Immune Cells Help Breast Tumors Thrive
MAR 18, 2021
"Brainwashed" Immune Cells Help Breast Tumors Thrive
Immunologists have discovered a mechanism through which immune cells get recruited into breast cancer tumors, and instea ...
MAR 22, 2021
Cell & Molecular Biology
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
MAR 22, 2021
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
Immunotherapy aims to make a patient's immune cells better at fighting cancer. The immune system has to be used carefull ...
APR 13, 2021
Immunology
The "Unexpected" Reason Why COVID Antivirals Don't Work
APR 13, 2021
The "Unexpected" Reason Why COVID Antivirals Don't Work
Purdue University researchers have made a breakthrough finding that could explain why the disease is so hard to manage t ...
JUN 01, 2021
Immunology
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
JUN 01, 2021
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
Seasonal flu vaccines only work around 40 to 60 percent of the time, says the U.S. Centers for Disease Control and Preve ...
JUN 11, 2021
Cell & Molecular Biology
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
JUN 11, 2021
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
The immune system can detect and destroy pathogenic and cancerous cells, but sometimes those dangerous cells can evade t ...
Loading Comments...